Science Market Update

Philadelphia Researchers Produce GM1 Ganglioside to Treat Parkinson's

Posted by Laura Braden on Tue, Jan 05, 2016

Researchers at Thomas Jefferson University are learning more about the neurodegenerative disease, Parkinson's. Parkinson's Disease is a devastating neurodegenerative disease that affects people's motor functions. As of today, there are no cures for Parkinson's Disease, and treatments are only able to alleviate symptoms. Researchers across the nation are heavily studying the disease, with the goal of learning more about the onset and progress of the disease to help scientists develop treatment methods.

Read More

Tags: Northeast, Thomas Jefferson University, Parkinson's Disease Research, Philadelphia, PA, ThomJeff, 2016, Parkinson's Disease, BioResearch Product Faire, GM1 ganglioside

Subscribe to Company News